By Counterforce Health Team in Cerezyme (imiglucerase) —

How to Get Cerezyme (Imiglucerase) Approved by UnitedHealthcare in New Jersey: Complete Appeals Guide

Answer Box: Getting Cerezyme Covered by UnitedHealthcare in New Jersey

Cerezyme (imiglucerase) requires prior authorization from UnitedHealthcare/OptumRx in New Jersey and may face step therapy requirements. To get coverage:

  1. Submit PA request via UnitedHealthcare Provider Portal with Gaucher disease confirmation and specialist documentation
  2. Request step therapy exception if required—cite contraindications, ineffectiveness, or adverse reactions to preferred alternatives
  3. Appeal promptly if denied—you have specific deadlines under New Jersey law, with external review through IHCAP available after internal appeals

First step today: Contact your prescribing physician to gather diagnostic confirmation (enzyme levels, genetic testing) and treatment history for the PA submission.

Table of Contents

Why New Jersey State Rules Matter

New Jersey's healthcare laws provide important protections that work alongside UnitedHealthcare's policies. The state's step therapy reform legislation and Independent Health Care Appeals Program (IHCAP) create additional pathways for patients who need specialty medications like Cerezyme.

Key New Jersey protections include:

  • Strict timelines for step therapy exception reviews (24-72 hours)
  • Mandatory disclosure of all coverage criteria
  • Independent external review through IHCAP after internal appeals
  • Provider right to file appeals on behalf of patients

These protections apply to most UnitedHealthcare plans in New Jersey, though ERISA self-funded employer plans follow different federal rules.

UnitedHealthcare PA Requirements for Cerezyme

UnitedHealthcare and OptumRx require prior authorization for Cerezyme across most New Jersey plans. Based on current PA requirements, the process involves:

Required Documentation:

  • Confirmed Type 1 Gaucher disease diagnosis (enzyme assay or genetic testing)
  • Specialist evaluation (hematologist, geneticist, or other qualified physician)
  • Clinical evidence supporting dosing rationale
  • Documentation of disease severity and treatment goals

Submission Methods:

Tip: Submit PA requests early in the treatment planning process. UnitedHealthcare typically requires 5-10 business days for standard reviews, though urgent cases may be expedited.

Step Therapy Protections in New Jersey

New Jersey's Assembly Bill A1825, effective January 2026 for state-regulated plans, strengthens step therapy override rights. For Cerezyme, step therapy exceptions can be requested if:

Medical Exception Criteria:

  • Required alternative drugs are contraindicated or likely to cause harm
  • Alternative drugs are expected to be ineffective based on clinical characteristics
  • All formulary alternatives have been tried and failed or caused adverse reactions

Timeline Requirements:

  • Urgent requests: Decision within 24 hours
  • Standard requests: Decision within 72 hours
  • Coverage duration: Minimum 180 days once approved

Documentation for Exceptions:

  • Clinical notes supporting medical necessity
  • Evidence of previous treatment failures or adverse reactions
  • Specialist attestation regarding appropriateness of step therapy alternatives

Appeals Process and Deadlines

New Jersey's Health Care Quality Act establishes specific appeal timelines that UnitedHealthcare must follow:

Internal Appeals

Stage 1:

  • Urgent cases: Decision within 72 hours
  • Standard cases: Decision within 10 days

Stage 2 (for group plans):

  • Urgent cases: Decision within 72 hours
  • Standard cases: Decision within 20 days

Required Appeal Elements

  • Copy of the denial notice
  • Supporting medical documentation
  • Written statement explaining why the denial should be overturned
  • Any additional evidence supporting medical necessity

Submit appeals through:

  • UnitedHealthcare member portal
  • Written appeal to the address on your denial letter
  • Provider can file on your behalf with authorization

External Review Through IHCAP

After completing internal appeals, New Jersey residents can request independent external review through the Independent Health Care Appeals Program (IHCAP), administered by Maximus Federal Services.

Eligibility:

  • Completed all required internal appeals with UnitedHealthcare
  • Denial based on medical necessity or similar coverage determination
  • Fully-insured commercial plan or NJ FamilyCare (not ERISA self-funded plans)

Filing Requirements:

  • Submit within 4 months (120 days) of final internal denial
  • $25 application fee (may be waived for financial hardship)
  • Complete medical records and specialist documentation

Timeline:

  • Preliminary review: 5 business days to confirm eligibility
  • Final decision: Within 45 days of complete submission
  • Expedited review: Available for urgent cases

Contact IHCAP at 1-888-393-1062 or submit through the Maximus NJ IHCAP Portal.

Coverage Requirements at a Glance

Requirement Details Source
Prior Authorization Required for most UHC/OptumRx plans UHC NJ PA Requirements
Step Therapy May apply; exceptions available Plan-specific formulary
Diagnosis Confirmed Type 1 Gaucher disease FDA labeling
Prescriber Specialist preferred UHC policy
Dosing 2.5-60 U/kg per FDA label FDA Orange Book
Appeal Deadline Internal: varies by urgency NJ Health Care Quality Act
External Review 4 months after final denial NJ IHCAP

Common Denial Reasons & Solutions

Denial Reason Solution Strategy
"Not medically necessary" Submit specialist letter with clinical guidelines citations and treatment goals
"Step therapy required" Request exception with documentation of contraindications or expected ineffectiveness
"Dosing outside guidelines" Provide weight-based calculations and specialist rationale per FDA labeling
"Lack of specialist evaluation" Obtain evaluation from hematologist, geneticist, or other qualified specialist
"Insufficient diagnostic confirmation" Submit enzyme assay results or genetic testing confirming Type 1 Gaucher disease

Clinician Corner: Medical Necessity Documentation

Healthcare providers can strengthen Cerezyme PA requests and appeals by including:

Essential Elements:

  • Confirmed Type 1 Gaucher disease diagnosis with enzyme levels or genetic testing
  • Clinical severity assessment (organomegaly, hematologic findings, bone involvement)
  • Treatment goals and expected outcomes
  • Rationale for specific dosing based on patient weight and disease severity
  • Monitoring plan for response assessment

Supporting Citations:

  • FDA prescribing information for approved indications
  • Relevant treatment guidelines from specialty societies
  • Peer-reviewed literature supporting dosing rationale

Appeal-Specific Documentation:

  • Point-by-point response to denial reasons
  • Clinical evidence contradicting plan's determination
  • Specialist attestation regarding medical necessity
From our advocates: "We've seen the strongest approvals when clinicians include both the diagnostic confirmation and a clear treatment rationale tied to specific clinical goals. Plans respond well to structured letters that address their coverage criteria directly while citing established guidelines."

When Your Plan Type Matters

Your appeal rights depend on your specific UnitedHealthcare plan type:

Fully-Insured Commercial Plans:

  • Full New Jersey appeal protections apply
  • IHCAP external review available
  • State-mandated timelines enforceable

ERISA Self-Funded Employer Plans:

  • Federal ERISA appeal rights only
  • No access to IHCAP external review
  • Different procedural requirements and timelines

Medicare Advantage:

  • Federal Medicare appeal process
  • No IHCAP eligibility
  • Administrative law judge hearings for higher-value claims

ACA Marketplace Plans:

  • New Jersey appeal protections apply
  • IHCAP external review available
  • Additional ACA-mandated protections

Contact your HR department or UnitedHealthcare member services to confirm your plan funding type if uncertain.

At Counterforce Health, we help patients and providers navigate these complex coverage requirements by analyzing denial letters, identifying the specific appeal strategy, and drafting evidence-backed responses that address payer policies directly.

Practical Scripts and Templates

Patient Phone Script for UnitedHealthcare

"I'm calling about prior authorization for Cerezyme for my Type 1 Gaucher disease. My physician submitted the request [date], and I need to check the status. My member ID is [number]. Can you tell me if any additional documentation is needed and what the expected timeline is for a decision?"

Step Therapy Exception Request

"I am requesting a step therapy exception for Cerezyme because [choose applicable]: the required alternative medications are contraindicated due to [specific reason], have been tried and failed [list medications and outcomes], or are expected to be ineffective based on my clinical characteristics and specialist evaluation."

Cost Support Options

Manufacturer Support:

  • Sanofi Genzyme may offer patient assistance programs
  • Contact manufacturer directly for eligibility requirements

State Programs:

  • New Jersey Pharmaceutical Assistance to the Aged and Disabled (PAAD)
  • Senior Gold Prescription Discount Program

Foundation Grants:

  • National Organization for Rare Disorders (NORD)
  • Patient Advocate Foundation
  • Good Days (formerly Chronic Disease Fund)

Copay Assistance:

  • Check manufacturer websites for current copay card programs
  • Eligibility typically excludes government insurance programs

FAQ

How long does UnitedHealthcare PA take in New Jersey? Standard PA requests typically take 5-10 business days. Urgent requests may be expedited to 24-72 hours if medical urgency is documented.

What if Cerezyme is non-formulary on my plan? Non-formulary drugs may still be covered through the medical exception process. Submit documentation showing medical necessity and why formulary alternatives are inappropriate.

Can I request an expedited appeal? Yes, if delays would seriously jeopardize your health. Mark appeals as "urgent" and include physician documentation of the time-sensitive nature.

Does step therapy apply if I was stable on Cerezyme before switching to UnitedHealthcare? New Jersey's continuity of care provisions may protect ongoing therapy. Request a transition fill while submitting a step therapy exception based on current stable treatment.

What happens if IHCAP overturns UnitedHealthcare's denial? The decision is binding. UnitedHealthcare must provide coverage as directed by the independent medical reviewers.

Can my doctor file appeals on my behalf? Yes, New Jersey law specifically allows providers to file appeals with patient authorization. This can be particularly helpful for complex specialty medication cases.

Disclaimer: This information is for educational purposes only and does not constitute medical advice. Coverage policies vary by plan and may change. Always consult your healthcare provider regarding treatment decisions and verify current policy requirements with UnitedHealthcare.

Need personalized help? Counterforce Health specializes in turning insurance denials into targeted appeals by analyzing your specific denial reasons and crafting evidence-backed responses aligned to your plan's coverage criteria.

Sources & Further Reading

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.